Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG
DE-104 ophthalmic solution, low concentration
DRUG
DE-104 ophthalmic solution, medium concentration
DRUG
DE-104 ophthalmic solution, high concentration
DRUG
DE-104 vehicle
Trial Locations (1)
Unknown
Osaka, Japan, Osaka
All Listed Sponsors
lead
Santen Pharmaceutical Co., Ltd.
INDUSTRY
NCT00657579 - Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter